WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017186889) PROTEIN BASED EXCIPIENT FOR ACTIVE PHARMACEUTICAL INGREDIENTS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/186889    International Application No.:    PCT/EP2017/060143
Publication Date: 02.11.2017 International Filing Date: 28.04.2017
Chapter 2 Demand Filed:    29.11.2017    
IPC:
A61K 47/42 (2017.01), A61K 47/34 (2017.01)
Applicants: ROUSSELOT B.V. [NL/NL]; Kanaaldijk Noord 20-21 5691 Son NM (NL)
Inventors: VERGAUWEN, Bjorn; (BE).
VAN DE MOOTER, Guy; (BE)
Agent: PAPPAERT, Kris; (BE).
PAEMEN, Liesbet; (BE).
BOUNAGA, Sakina; (BE).
DE CLERCQ, Ann; (BE).
MICHALÍK, Andrej; (BE).
VANHALST, Koen; (BE).
GYI, Jeffrey; (BE).
BOGAERTS, Sven; (BE).
DE CLERCQ, Annelies; (BE).
DEBRUYNE, Delphine; (BE).
LESTHAEGHE, David; (BE).
HENNIN, Caroline; (BE).
GOESAERT, Hans; (BE).
VIAENE, Ann; (BE)
Priority Data:
2016/5302 29.04.2016 BE
2016/5977 26.12.2016 BE
Title (EN) PROTEIN BASED EXCIPIENT FOR ACTIVE PHARMACEUTICAL INGREDIENTS
(FR) EXCIPIENT À BASE DE PROTÉINES DESTINÉ À DES PRINCIPES ACTIFS PHARMACEUTIQUES
Abstract: front page image
(EN)Provided herein is a pharmaceutical formulation comprising a protein based excipient in combination with an active pharmaceutical ingredient (API) wherein said formulation is substantially amorphous and form a substantially homogenous mixture; and further a method for producing said pharmaceutical formulation; and said pharmaceutical formulation for use as a medicament.
(FR)L'invention concerne une formulation pharmaceutique comprenant un excipient à base de protéines en association avec un principe actif pharmaceutique (API), ladite formulation étant sensiblement amorphe et formant un mélange sensiblement homogène ; l'invention concerne en outre un procédé de production de ladite formulation pharmaceutique ; et ladite formulation pharmaceutique destinée à être utilisée comme médicament.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)